BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 171062)

  • 1. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
    Mandato E; Meldolesi MF; Macchia V
    Cancer Res; 1975 Nov; 35(11 Pt 1):3089-93. PubMed ID: 171062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
    Yamashita K; Field JB
    J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in TSH-receptor in two transplantable rat thyroid tumors.
    Macchia V; Meldolesi MF; Mandato E
    Ann Radiol (Paris); 1977; 20(8):752-6. PubMed ID: 205162
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
    Clark OH; Gerend PL
    Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
    Pasquali D; Rani CS; Deery WJ
    Mol Pharmacol; 1992 Jan; 41(1):163-7. PubMed ID: 1310140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of anti-thyrotropin anti-idiotypic antibody.
    Islam MN; Pepper BM; Briones-Urbina R; Farid NR
    Eur J Immunol; 1983 Jan; 13(1):57-63. PubMed ID: 6299753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sulfhydryl groups in thyrotropin binding and adenylate cyclase activities of thyroid plasma membranes.
    Ozawa Y; Chopra IJ; Solomon DH; Smith F
    Endocrinology; 1979 Nov; 105(5):1221-5. PubMed ID: 226349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH; Gerend PL; Goretzki P; Nissenson RA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
    Clark OH; Gerend PL; Nissenson RA
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M
    J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sialic acid on adenylate cyclase activity and thyrotropin-receptor binding in human thyroid membranes.
    Adler GM
    Acta Biochim Pol; 1978; 25(4):343-7. PubMed ID: 220831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.
    Auf'mkolk M; Ingbar JC; Amir SM; Winterhoff H; Sourgens H; Hesch RD; Ingbar SH
    Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP; Amr S; Carayon P; Nisula BC
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE; Wahl RA; Branscheid D; Roeher HD
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous forms of thyroid-stimulating hormone in mouse thyrotropic tumor and serum: differences in receptor-binding and adenylate cyclase-stimulating activity.
    Pekonen F; Carayon P; Amr S; Weintraub BD
    Horm Metab Res; 1981 Nov; 13(11):617-20. PubMed ID: 6273277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity.
    Carayon P; Thomas-Morvan C; Castanas E; Tubiana M
    J Clin Endocrinol Metab; 1980 Oct; 51(4):915-20. PubMed ID: 7419673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell membrane of thyroid and its altered responsiveness to the hormone TSH.
    Macchia V; Meldolesi MF
    Adv Cytopharmacol; 1974; 2():33-7. PubMed ID: 4440562
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH; Gerend PL; Cote TC; Nissenson RA
    Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in the transmission of TSH-message to thyroid target in a transplantable rat thyroid tumor.
    Laccetti P; Meldolesi MF; Beguinot L; Mariano A; Macchia V
    J Endocrinol Invest; 1986 Oct; 9(5):359-66. PubMed ID: 3794181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.